Two new medications to fight drug-resistant superbugs soon available on NHS

Two new drugs which fight superbugs could soon become available to NHS patients in England.

 

Drugs’ watchdog NICE say ceftazidime with avibactam and cefiderocol offer value for money and may save lives.

 

These ‘last line of defence’ drugs will tackle severe infections which cannot be cleared by other treatments.

 

Antimicrobial resistance is a crucial issue which threatens to set back modern medicine to the pre-antibiotic era.  Without effective medication to address superbugs, routine surgery, such as hip and knee replacements, will become too dangerous to perform.

 

Blake Dark, NHS commercial medicines director, said “This is an important step in our world-leading approach to incentivise innovation in antimicrobial drugs and the battle against drug-resistant infections.

 

“The NHS will now use its commercial power to secure deals that will enable NHS patients to benefit from these treatments, delivering on its Long Term Plan commitment and paving the way for a pipeline of future treatment options.”

 

Chadwick Lawrence’s specialist team of clinical negligence lawyers have years of experience in medical negligence claims, providing support and guidance after life-changing events.  Not only do we represent clients in Yorkshire, but because of our reputation we also represent clients nationally.

 

If you believe that you or a relative may have been injured as a result of clinical/medical negligence, please call for free legal advice from our medical negligence solicitors on the freephone number below.

 

Posted by Karen Motley, Clinical Negligence Department, Chadwick Lawrence LLP (tonymay@chadlaw.co.uk ), medical negligence lawyers and clinical negligence solicitors in Huddersfield, Leeds, Wakefield and Halifax, West Yorkshire.

 

Freephone : 0800 304 7382